최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.34 no.2, 2024년, pp.94 - 104
권재임 (동의대학교 항노화연구소) , 최영현 (동의대학교 항노화연구소) , 황보현 (동의대학교 항노화연구소)
β-Lapachone is a natural quinone compound originally obtained from the bark of the lapacho tree (Tabebuia vellanedae), which has been used in traditional medicine in several South and Central American countries for treating various diseases. Although β-lapachone has been reported to ha...
Alam, M., Ali, S., Mohammad, T., Hasan, G. M., Yadav,?D. K., Hassan, M. I. 2021. B cell lymphoma 2: A potential?therapeutic target for cancer therapy. Int. J. Mol. Sci. 22, 10442.
Alanazi, A. D., Ben Said, M. 2022. Plant bioactive ingredients in delivery systems and nanocarriers for the?treatment of leishmaniasis: An evidence-based review.?Iran. J. Parasitol. 17, 458-472.
Barot, S., Patel, H., Yadav, A., Ban, I. 2023. Recent advancement in targeted therapy and role of emerging technologies to treat cancer. Med. Oncol. 40, 324.
Chirumbolo, S., Bjorklund, G., Lysiuk, R., Vella, A.,?Lenchyk, L., Upyr, T. 2018. Targeting cancer with phytochemicals via their fine tuning of the cell survival signaling pathways. Int. J. Mol. Sci. 19, 3568.
Contadini, C., Ferri, A., Cirotti, C., Stupack, D., Barila, D. 2023. Caspase-8 and tyrosine kinases: A dangerous liaison in cancer. Cancers (Basel) 15, 3271.
D'Anneo, A., Augello, G., Santulli, A., Giuliano, M., di?Fiore, R., Messina, C., Tesoriere, G., Vento, R. 2010.?Paclitaxel and β-lapachone synergistically induce apoptosis in human retinoblastoma Y79 cells by downregulating?the levels of phospho-Akt. J. Cell Physiol. 222, 433-443.
Derakhshan, A., Chen, Z., Van Waes, C. 2017. Therapeutic?small molecules target inhibitor of apoptosis proteins in cancers with deregulation of extrinsic and intrinsic cell?death pathways. Clin. Cancer Res. 23, 1379-1387.
Dias, R. B., de Araujo, T. B. S., de Freitas, R. D., Rodrigues,?A. C. B. D. C., Sousa, L. P., Sales, C. B. S, Valverde,?L. F., Soares, M. B. P., Dos Reis, M. G., Coletta, R. D.,?Ramos, E. A. G., Camara, C. A., Silva, T. M. S., Filho,?J. M. B., Bezerra, D. P., Rocha, C. A. G. 2018. β-Lapachone and its iodine derivatives cause cell cycle arrest?at G2/M phase and reactive oxygen species-mediated?apoptosis in human oral squamous cell carcinoma cells.?Free Radic. Biol. Med. 126, 87-100.
Eisenbeis, V. B., Qiu, D., Gorka, O., Strotmann, L., Liu,?G., Prucker, I., Su, X. B., Wilson, M. S. C., Ritter, K.,?Loenarz, C., Gross, O., Saiardi, A., Jessen, H. J. 2023. β-lapachone regulates mammalian inositol pyrophosphate?levels in an NQO1- and oxygen-dependent manner. Proc.?Natl. Acad. Sci. USA. 120, e2306868120.
Espinosa-Oliva, A. M., Garcia-Revilla, J., Alonso-Bellido,?I. M., Burguillos, M. A. 2019. Brainiac caspases: Beyond?the wall of apoptosis. Front. Cell Neurosci. 13, 500.
Gencheva, R., Arner, E. S. J. 2022. Thioredoxin reductase?inhibition for cancer therapy. Annu. Rev. Pharmacol.?Toxicol. 62, 177-196.
Ghareeb, H., Metanis, N. 2020. The thioredoxin system:?A promising target for cancer Drug development. Chemistry 26, 10175-10184.
Gupta, D., Podar, K., Tai, Y. T., Lin, B., Hideshima, T.,?Akiyama, M., LeBlanc, R., Catley, L., Mitsiades, N.,?Mitsiades, C., Chauhan, D., Munshi, N. C., Anderson, K.?C. 2002. β-Lapachone, a novel plant product, overcomes drug resistance in human multiple myeloma cells. Exp.?Hematol. 30, 711-720.
Han, Y., Shi, D., Li, J. 2019. Inhibition of nasopharyngeal?carcinoma by β-lapachone occurs by targeting the mammalian target of rapamycin (mTOR)/PI3K/AKT pathway,?reactive oxygen species (ROS) production, and autophagy?induction. Med. Sci. Monit. 25, 8995-9002.
Hasan, A. A., Kalinina, E., Tatarskiy, V., Shtil, A. 2022.?The thioredoxin system of mammalian cells and its modulators. Biomedicines 10, 1757.
Hashem, S., Ali, T. A., Akhtar, S., Nisar, S., Sageena, G.,?Ali, S., Al-Mannai, S., Therachiyil, L., Mir, R., Elfaki, I.,?Mir, M.M., Jamal, F., Masoodi, T., Uddin, S., Singh, M.,?Haris, M., Macha, M., Bhat, A. A. 2022. Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents. Biomed. Pharmacother. 150, 113054.
He, T., Banach-Latapy, A., Vernis, L., Dardalhon, M.,?Chanet, R., Huang, M. E. 2013. Peroxiredoxin 1 knock- down potentiates β-lapachone cytotoxicity through modulation of reactive oxygen species and mitogen-activated?protein kinase signals. Carcinogenesis 34, 760-769.
He, T., Hatem, E., Vernis, L., Huang, M. E. 2014. Peroxiredoxin 1 knockdown sensitizes cancer cells to reactive?oxygen species-generating drugs - an alternative approach?for chemotherapy. Free Radic. Biol. Med. 75, S13.
Hounsell, C., Fan, Y. 2021. The Duality of caspases in?cancer, as told through the fly. Int. J. Mol. Sci. 22, 8927.
Hwangbo, H., Kim, S. Y., Lee, H., Park, S. H., Hong,?S. H., Park, C., Kim, G. Y., Leem, S. H., Hyun, J. W.,?Cheong, J., Choi, Y. H. 2020. Auranofin enhances sulforaphane-mediated apoptosis in hepatocellular carcinoma?Hep3B cells through inactivation of the PI3K/Akt signaling pathway. Biomol. Ther. (Seoul) 28, 443-455.
Hwangbo, H., Lee, H., Cheong, J. H., Choi, Y. H. 2022.?Recent research trends for thioredoxin reductase-targeted?anticancer therapy. J. Life Sci. 32, 63-69.
Hwang-Bo, H., Lee, W. S., Nagappan, A., Kim, H. J.,?Panchanathan, R., Park, C., Chang, S. H., Kim, N. D.,?Leem, S. H., Chang, Y. C., Kwon, T. K., Cheong, J. H.,?Kim, G. S., Jung, J. M., Shin, S. C., Hong, S. C., Choi.?Y. H. 2019. Morin enhances auranofin anticancer activity?by up-regulation of DR4 and DR5 and modulation of Bcl-2?through reactive oxygen species generation in Hep3B human hepatocellular carcinoma cells. Phytother. Res. 33, 1384-1393.
Iida, M., Harari, P. M., Wheeler, D. L., Toulany, M. 2020.?Targeting AKT/PKB to improve treatment outcomes for?solid tumors. Mutat. Res. 819-820, 111690.
Jastrzab, A., Skrzydlewska, E. 2021. Thioredoxin-dependent system. Application of inhibitors. J. Enzyme Inhib.?Med. Chem. 36, 362-371.
Jung, E. J., Kim, H. J., Shin, S. C., Kim, G. S., Jung, J.?M., Hong, S. C., Kim, C. W., Lee, W. S. 2023. β-Lapachone exerts anticancer effects by downregulating p53,?lys-acetylated proteins, TrkA, p38 MAPK, SOD1, caspase-2, CD44 and NPM in oxaliplatin-resistant HCT116?colorectal cancer cells. Int. J. Mol. Sci. 24, 9867.
Kaloni, D., Diepstraten, S. T., Strasser, A., Kelly, G. L. 2023. BCL-2 protein family: attractive targets for cancer therapy. Apoptosis 28, 20-38.
Kee, J. Y, Han, Y. H., Kim, D. S., Mun, J. G., Park, S.?H., So, H. S., Park, S. J., Park, R., Um, J. Y., Hong, S.?H. 2017. β-Lapachone suppresses the lung metastasis of?melanoma via the MAPK signaling pathway. PLoS One?12, e0176937.
Khezri, M. R., Jafari, R., Yousefi, K., Zolbanin, N. M.?2022. The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions.?Exp. Mol. Pathol. 127, 104787.
King, L. E., Hohorst, L., Garcia-Saez, A. J. 2023. Expanding roles of BCL-2 proteins in apoptosis execution and?beyond. J. Cell Sci. 136, jcs260790.
Lee, E. J., Ko, H. M., Jeong, Y. H., Park, E. M., Kim,?H. S. 2015. β-Lapachone suppresses neuroinflammation by?modulating the expression of cytokines and matrix metal-loproteinases in activated microglia. J. Neuroinflammation?12, 133.
Lee, J. I., Choi, D. Y., Chung, H. S., Seo, H. G., Woo,?H. J., Choi, B. T., Choi, Y. H. 2006. β-Lapachone induces?growth inhibition and apoptosis in bladder cancer cells by?modulation of Bcl-2 family and activation of caspases.?Exp. Oncol. 28, 30-35.
Li, Y. Z., Li, C.J., Pinto, A. V., Pardee, A. B. 1999. Release?of mitochondrial cytochrome C in both apoptosis and necrosis induced by β-lapachone in human carcinoma cells.?Mol. Med. 5, 232-239.
Lien, Y. C., Kung, H. N., Lu, K. S., Jeng, C. J., Chau,?Y. P. 2008. Involvement of endoplasmic reticulum stress?and activation of MAP kinases in β-lapachone-induced human prostate cancer cell apoptosis. Histol. Histopathol. 23, 1299-1308.
Liu, T. J., Lin, S. Y., Chau, Y. P. 2002. Inhibition of poly?(ADP-ribose) polymerase activation attenuates β-lapachone-induced necrotic cell death in human osteosarcoma?cells. Toxicol. Appl. Pharmacol. 182, 116-125.
Moon, D. O., Choi, Y. H., Kim, N. D., Park, Y. M., Kim,?G. Y. 2007. Anti-inflammatory effects of β-lapachone in?lipopolysaccharide-stimulated BV2 microglia. Int. Immunopharmacol. 7, 506-514.
Nainu, F., Frediansyah, A., Mamada, S. S., Permana, A.?D., Salampe, M., Chandran, D., Emran. T. B., Simal-Gandara, J. 2023. Natural products targeting inflammation-related metabolic disorders: A comprehensive review.?Heliyon 9, e16919.
Pardee, A. B., Li, Y. Z., Li, C. J. 2002. Cancer therapy?with β-lapachone. Curr. Cancer Drug Targets 2, 227-242.
Park, E. J., Min, K. J., Lee, T. J., Yoo, Y. H., Kim, Y.?S., Kwon, T. K. 2014. β-Lapachone induces programmed?necrosis through the RIP1-PARP-AIF-dependent pathway?in human hepatocellular carcinoma SK-Hep1 cells. Cell?Death Dis. 5, e1230.
Park, J. H., Kim, Y. S., Lee, H. L., Shim, J. Y., Lee, K.?S., Oh, Y. J., Shin, S. S., Choi, Y. H., Park, K. J., Park,?R. W., Hwang, S. C. 2006. Expression of peroxiredoxin?and thioredoxin in human lung cancer and paired normal?lung. Respirology 11, 269-275.
Park, J. S., Lee, Y. Y., Kim, J., Seo, H., Kim, H. S. 2016.?β-Lapachone increases phase II antioxidant enzyme expression via NQO1-AMPK/PI3K-Nrf2/ARE signaling in?rat primary astrocytes. Free Radic. Biol. Med. 97, 168-178.
Peng, Y., Wang, Y., Zhou, C., Mei, W., Zeng, C. 2022.?PI3K/Akt/mTOR pathway and its role in cancer therapeutics: Are we making headway? Front. Oncol. 12, 819128.
Planchon, S. M., Wuerzberger-Davis, S. M., Pink, J. J.,?Robertson, K. A., Bornmann, W. G., Boothman, D. A.?1999. Bcl-2 protects against β-lapachone-mediated caspase?3 activation and apoptosis in human myeloid leukemia?(HL-60) cells. Oncol. Rep. 6, 485-492.
Qadir, M. I., Iqbal, M. S., Khan, R. 2022. β-lapachone:?A promising anticancer agent with a unique NQO1 specific apoptosis in pancreatic cancer. Curr. Cancer Drug?Targets. 22, 537-540.
Qian, S., Wei, Z., Yang, W., Huang, J., Yang, Y., Wang,?J. 2022. The role of BCL-2 family proteins in regulating?apoptosis and cancer therapy. Front. Oncol. 12, 985363.
Shillingford, S. R., Bennett, A. M. 2023. Mitogen-activated?protein kinase phosphatases: No longer undruggable??Annu. Rev. Pharmacol. Toxicol. 63, 617-636.
Siripong, P., Hahnvajanawong, C., Yahuafai, J., Piyaviri- yakul, S., Kanokmedhakul, K., Kongkathip, N., Ruchirawat, S., Oku, N. 2009. Induction of apoptosis by rhinacanthone isolated from Rhinacanthus nasutus roots in human cervical carcinoma cells. Biol. Pharm. Bull. 32, 1251-1260.
Starcher, C. L., Pay, S. L., Singh, N., Yeh, I. J., Bhandare,?S. B., Su, X., Huang, X., Bey, E. A., Motea, E. A., Boothman, D. A. 2020. Targeting base excision repair in cancer: NQO1-bioactivatable drugs improve tumor selectivity and?reduce treatment toxicity through radiosensitization of human cancer. Front. Oncol. 10, 1575.
Tikkanen, R., Nikolic-Paterson, D. J. 2019. Mitogen-activated protein kinases: Functions in signal transduction and?human diseases. Int. J. Mol. Sci. 20, 4844.
Wagner, E. F., Nebreda, A. R. 2009. Signal integration?by JNK and p38 MAPK pathways in cancer development.?Nat. Rev. Cancer 9, 537-549.
Wen, C., Wang, H., Wu, X., He, L., Zhou, Q., Wang,?F., Chen, S., Huang, L., Chen, J., Wang, H., Ye, W., Li,?W., Yang, X., Liu, H., Peng, J. 2019. ROS-mediated inactivation of the PI3K/AKT pathway is involved in the?antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin. Cell Death Dis. 10, 809.
Wen, X., Lin, Z. Q., Liu, B., Wei, Y. Q. 2012. Caspase-mediated programmed cell death pathways as potential?therapeutic targets in cancer. Cell Prolif. 45, 217-224.
Woo, H. J., Park, K. Y., Rhu, C. H., Lee, W. H., Choi,?B. T., Kim, G. Y., Park, Y. M., Choi, Y. H. 2006. β-Lapachone, a quinone isolated from Tabebuia avellanedae, induces apoptosis in HepG2 hepatoma cell line?through induction of Bax and activation of caspase. J.?Med. Food 9, 161-168.
Yang, Y., Zhou, X., Xu, M., Piao, J., Zhang, Y., Lin, Z.,?Chen, L. 2017. β-lapachone suppresses tumour progression?by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers. Sci. Rep. 7, 2681.
Yu, H. Y., Kim, S. O., Jin, C. Y., Kim, G. Y., Kim, W.?J., Yoo, Y. H., Choi, Y. H. 2014. β-Lapachone-induced?apoptosis of human gastric carcinoma AGS cells is caspase-dependent and regulated by the PI3K/Akt pathway.?Biomol. Ther. (Seoul) 22, 184-192.
Yue, J., Lopez, J. M. 2020. Understanding MAPK signaling pathways in apoptosis. Int. J. Mol. Sci. 21, 2346.
Zhang, J., Xu, Q., Ma, D. 2022. Inhibition of thioredoxin?reductase by natural anticancer candidate β-lapachone accounts for triggering redox activation-mediated HL-60 cell?apoptosis. Free Radic. Biol. Med. 180, 244-252.
Zhou, Z., Xu, S., Jiang, L., Tan, Z., Wang, J. 2022. A?systematic pan-cancer analysis of CASP3 as a potential?target for immunotherapy. Front. Mol. Biosci. 9, 776808.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.